Skip to main content

Closed

AXGN: AxoGen, Inc. Stock Analysis | finqOS

Healthcare · Medical - Devices

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+17.8% / yr

Operating margin-5.1%

ROIC-4.6%

Financially safe

Stretched

Debt / equity0.08×

Interest coverage-1.0×

Current ratio6.60×

AxoGen, Inc.

AXGNNASDAQ Capital Market·USD·Closed

AxoGen, Inc.

AXGNNASDAQ·USD·Closed

$42.21

+2.08%

$42.21

+$0.86 (2.08%)

52W Range

86thpctl

Volume

0.98×avg

Mkt Cap

2.27BUSD

P/E

-62.6TTM

Div Yield

–ann

52W Range

86thpctl

Volume

0.98×avg

Market Cap

2.27BUSD

P/E Ratio

-62.6TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings